Phenibut HCl
weak data5 sources
Phenibut is the GABA-B compound everyone starts with, and in my experience it barely did anything. Easy to end up chasing the dose or using it to lower a drinking tolerance, which is a bad road. It also carries the worst dependence and withdrawal profile of this family, with 48.7% of published toxicity cases requiring intubation. Pregabalin and baclofen outclass it for the same goal, with better effects and more predictable pharmacology. If you run phenibut anyway, the harm-reduction rules are non-negotiable.
What it is
Phenibut is a phenylated analogue of GABA that crosses the blood-brain barrier where GABA itself cannot. It acts at GABA-B receptors, the same target baclofen hits, and at the alpha-2-delta calcium-channel subunit, the same target pregabalin and gabapentin hit. On paper that dual action sounds like an advantage. In practice, it hits neither target as cleanly or as predictably as the dedicated compounds, and the community experience reflects that: underwhelming effects chased by escalating doses.
Phenibut is sold online as a supplement in most Western countries. It is prescribed in Russia and some former Soviet states for anxiety and sleep. The unregulated supply introduces its own problem: lab testing of online products has found wildly inconsistent content, with some capsules containing far less phenibut than labeled and others far more.
What the research shows
The evidence base is thin, and the safety literature is thicker than the efficacy literature, which tells you something. Published dependence and intoxication cases range from 0.5 to 100 g/day against a stated recommended range of 0.25 to 2 g/day, and that spread says everything about where chasing the dose leads:
Realistic protocols
Pregabalin and baclofen do this job better, but if you run phenibut, these rules apply without exception.
First, sourcing. The product-testing data above is the reason: no COA, no order. Require a third-party certificate of analysis from whatever supplier you consider, and walk away without one. You do not know what is in an untested capsule.
The harm-reduction rules, same family: one to two times a week maximum, never daily, never with alcohol or other depressants. Daily phenibut use builds dependence faster than the other GABAergics on this shelf, and the withdrawal is documented and ugly, including psychosis and hospital admissions. The weekly cadence is not a guideline, it is the line between a useful tool and a dependency.
The community dose range runs from 500 mg to about 2 g. Start at 500 mg on an empty stomach. Give it 2 to 3 hours to hit, because the onset is slow and the tail is long, and redosing before you feel the first dose is how people end up in trouble. That slow onset and long duration is also why the once-or-twice-a-week rule bites harder here than anywhere else on this shelf: the compound is still working when you think it is not. If 500 mg does nothing, try 750 mg next time, not the same day. The effect at its best is a mild calm with some sociability, nowhere near what pregabalin delivers. If you find yourself pushing past 1.5 g and still chasing something, the honest answer is that phenibut is not your compound.
Side effects
Phenibut’s side-effect and risk profile is the worst in this family, driven almost entirely by the dependence and withdrawal picture: